Kenyan politician and former Defence Secretary
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
Kenya has confirmed its first imported case of Bundibugyo Ebola after a Kenyan who fell ill in the Democratic Republic of Congo travelled by road through Uganda and flew to Nairobi on Oct. 3. The patient has tested positive, died on Oct. 5, and authorities have identified dozens of contacts and begun tracing passengers from the flight.
Kenya has confirmed nine Ebola cases linked to an initial patient who travelled from the DRC. Authorities say there is no evidence of wider community transmission, and quarantine measures have been maintained while contact tracing continues.
Kenya has identified 135 contacts from the initial Ebola case and has traced and quarantined 118; nine cases have been confirmed with two deaths. Authorities say the outbreak is contained within a single transmission cluster and no new infections have been recorded since Oct. 19. Discharges are planned for contacts after completing 21 days of monitoring.
Kenya has discharged seven Ebola patients and completed follow-up for all identified contacts after the first patient’s travel from the DRC. The government says a 42-day countdown to being Ebola-free is underway, with surveillance and border measures remaining in place as nations reassess travel rules.